Metastatic Non-Small-Cell Lung Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Published in 2018 – Ann Oncol (2018) 29 (suppl 4): iv192–iv237
Authors: D. Planchard, S. Popat, K. Kerr, S. Novello, E. F. Smit, C. Faivre-Finn, T. S. Mok, M. Reck, P. E. Van Schil, M. D. Hellmann & S. Peters, on behalf of the ESMO Guidelines Committee

The 2018 ESMO Clinical Practice Guidelines on Metastatic non-small cell lung cancer (NSCLC) are based on results from recent studies and analyses. The guidelines focus on treatment recommendations for the management of advanced/metastatic NSCLC, with an update on the role of immunotherapy and the use of targeted therapies for patients with tumours with specific gene mutations. Also covered are personalised medicine recommendations and new treatment algorithms.

Download the PDF from Annals of Oncology
Last update: 04 October 2018